ReviewBiochemical Society transactions2025
The exit from naive pluripotency: a platform for the study of enhancer mechanistics.
Review in Biochemical Society transactions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multicellular life depends on the ability to activate and repress genes in a highly context-specific manner. With each cell state transition, a new transcriptional profile is established. As non-coding DNA elements, enhancers mediate their regulatory potential through the effectors they recruit. While ultimately instructed by the underlying DNA sequence, enhancer activity depends on several factors, such as transcription factor availability, chromatin state, and promoter proximity, all of which are dynamically regulated within the cell. Even when we understand the regulation of one enhancer, its genomic impact is dependent on its integration within the regulatory landscape. Thus, a full picture of enhancer dynamics can only be painted through broad, but controlled, approaches that integrate investigations into multiple levels of gene regulatory mechanisms. In this review, we will present the exit of naive pluripotency as a prime setting to do just that and contextualize how its contemporary use has been, and could be, used to reveal the intricacies of enhancer mechanistics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.